CPC A61K 35/16 (2013.01) [A61P 31/20 (2018.01); C07K 16/4283 (2013.01)] | 13 Claims |
1. A method for inhibiting cytomegalovirus (CMV) reactivation in a transplant recipient with a CMV-seropositive serological status, the method comprising obtaining serum and/or plasma from the transplant recipient prior to transplantation and administering an effective amount of the serum and/or plasma, or a component thereof, to the transplant recipient before, concomitant with or after transplantation, wherein the serum or plasma or component thereof comprises one or more anti-CMV antibodies.
|